Santhera Pharmaceuticals Holding AG (SANN)

Currency in CHF
15.00
+0.80(+5.63%)
Closed·
SANN Scorecard
Full Analysis
Quickly burning through cash
Unusual trading volume
Fair Value
Day's Range
14.2215.40
52 wk Range
7.2117.76
Key Statistics
Bid/Ask
15.00 / 15.20
Prev. Close
14.2
Open
14.22
Day's Range
14.22-15.4
52 wk Range
7.21-17.76
Volume
72.45K
Average Volume (3m)
30.78K
1-Year Change
53.85%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SANN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
30.00
Upside
+100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Santhera Pharmaceuticals Holding AG Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.

Employees
79

Compare SANN to Peers and Sector

Metrics to compare
SANN
Peers
Sector
Relationship
P/E Ratio
−4.6x−3.2x−0.5x
PEG Ratio
0.03−0.060.00
Price/Book
7.0x1.5x2.6x
Price / LTM Sales
5.0x6.5x3.2x
Upside (Analyst Target)
100.0%93.8%41.6%
Fair Value Upside
Unlock−1.4%6.0%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 30.00
(+100.00% Upside)

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-0.74 / -0.92
Revenue / Forecast
9.00M / 7.30M
EPS Revisions
Last 90 days

SANN Income Statement

People Also Watch

2.3500
RLFB
+1.51%
93.34
NOVN
+0.53%
8.80
CLN
-0.68%

FAQ

What Stock Exchange Does Santhera Pharmaceuticals Holding Trade On?

Santhera Pharmaceuticals Holding is listed and trades on the Switzerland Stock Exchange stock exchange.

What Is the Stock Symbol for Santhera Pharmaceuticals Holding?

The stock symbol for Santhera Pharmaceuticals Holding is "SANN."

What Is the Santhera Pharmaceuticals Holding Market Cap?

As of today, Santhera Pharmaceuticals Holding market cap is 193.07M.

What Is Santhera Pharmaceuticals Holding's Earnings Per Share (TTM)?

The Santhera Pharmaceuticals Holding EPS (TTM) is -3.69.

When Is the Next Santhera Pharmaceuticals Holding Earnings Date?

Santhera Pharmaceuticals Holding will release its next earnings report on 09 Sept 2025.

From a Technical Analysis Perspective, Is SANN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Santhera Pharmaceuticals Holding Stock Split?

Santhera Pharmaceuticals Holding has split 1 times.

How Many Employees Does Santhera Pharmaceuticals Holding Have?

Santhera Pharmaceuticals Holding has 79 employees.

What is the current trading status of Santhera Pharmaceuticals Holding (SANN)?

As of 28 Jul 2025, Santhera Pharmaceuticals Holding (SANN) is trading at a price of 15.00, with a previous close of 14.20. The stock has fluctuated within a day range of 14.22 to 15.40, while its 52-week range spans from 7.21 to 17.76.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.